Alzamend Neuro (ALZN) Selling, General & Administrative (2020 - 2026)
Alzamend Neuro (ALZN) reported Selling, General & Administrative of $1.94 million for fiscal Q1 2027 (quarter ended Jul 31, 2026), up 102.2% from $959,334 a year earlier but down 20.4% from the prior quarter.
Alzamend Neuro (ALZN) Selling, General & Administrative (2020 - 2026) Analysis & Trends
Over the twelve months ended Jul 31, 2026, Alzamend Neuro's Selling, General & Administrative came in at $6.12 million, up 86.2% year-over-year; for FY2026 (ended Apr 30, 2026), it came in at $5.14 million, up 66.7% from FY2025.
- Selling, General & Administrative has a five-year compound annual growth rate of 7.1% (FY2021 to FY2026).
- By fiscal year, Selling, General & Administrative came in at $3.08 million in FY2025 (-11.5%), $3.48 million in FY2024 (-53.1%), $7.42 million in FY2023 (+4.3%) and $7.12 million in FY2022 (+95.5%).
- Five-year quarterly Selling, General & Administrative spans a low of $590,304 in fiscal Q3 2025 and a high of $2.53 million in fiscal Q3 2023.
- Year over year, Selling, General & Administrative has now increased in each of the last three quarters, with growth averaging 51.8% over the last eight quarters.
- The high point for year-over-year Selling, General & Administrative in five years was fiscal Q4 2026 (growth of 253.8%); the low point was fiscal Q3 2024 (a decline of 70.4%).
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $2.44 million (Q4 2026), $919,025 (Q3 2026) and $821,826 (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Alzamend Neuro | 6.61 Mn | 6.61 Mn | - | 1.94 Mn |
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 1.94 Mn |
| Apr 30, 2026 | 2.44 Mn |
| Jan 31, 2026 | 919,025.00 |
| Oct 31, 2025 | 821,826.00 |
| Jul 31, 2025 | 959,334.00 |
| Apr 30, 2025 | 688,779.00 |
| Jan 31, 2025 | 590,304.00 |
| Oct 31, 2024 | 1.05 Mn |
| Jul 31, 2024 | 755,834.00 |
| Apr 30, 2024 | 666,634.00 |
| Jan 31, 2024 | 751,173.00 |
| Oct 31, 2023 | 904,939.00 |
| Jul 31, 2023 | 1.16 Mn |
| Apr 30, 2023 | 1.66 Mn |
| Jan 31, 2023 | 2.53 Mn |
| Oct 31, 2022 | 1.57 Mn |
| Jul 31, 2022 | 1.66 Mn |
| Apr 30, 2022 | 2.21 Mn |
| Jan 31, 2022 | 1.68 Mn |
| Oct 31, 2021 | 1.83 Mn |
Alzamend Neuro Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ALZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "ALZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ALZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();